NCT02533531 is a NA clinical trial of 1-Lead Patch in Telemetry, sponsored by LifeWatch Services, Inc..

Who is sponsoring NCT02533531?

NCT02533531 is sponsored by LifeWatch Services, Inc..

What drugs are being tested in NCT02533531?

Interventions in NCT02533531: 1-Lead Patch.

Is NCT02533531 still recruiting?

NCT02533531 is currently terminated. Last updated 6 April 2018.

Are results published for NCT02533531?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2018-04-06 · How we verify

NCT02533531

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Proof of Concept Study for 1 Lead Patch Technology

Terminated NA Results posted Last updated 6 April 2018

What this trial tests

NA trial testing 1-Lead Patch in Telemetry in 1 participant. Terminated before completion.

Timeline

16 April 2014

Primary endpoint
9 June 2016

9 June 2016

Quick facts

Lead sponsor	LifeWatch Services, Inc.
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	1
Start date	16 April 2014
Primary completion	9 June 2016
Estimated completion	9 June 2016
Sites	1 location across United States

Drugs / interventions tested

1-Lead Patch

Conditions studied

Telemetry — all drugs for Telemetry →

Sponsor

LifeWatch Services, Inc.

Who can join

21 and older, any sex, with Telemetry. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is intended to assess the feasibility and usability of the 1 Lead Patch as a whole, on patients outside the hospital, in the out-patient setting.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other LifeWatch Services, Inc. trials

Trials by the same sponsor.

NCT02518100 — Vital Signs Patch: Automated Monitoring of Vital Signs Measurements in the In-Patient Hospital Setting · NA · completed
NCT02521922 — Vital Signs Patch Early Feasibility and Usability Study · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02533531 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by LifeWatch Services, Inc.
Last refreshed: 6 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02533531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing